Legal Representation
Attorney
Alexander Lazouski
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description |
|---|---|---|---|
| May 19, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| May 19, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| May 19, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Apr 14, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 14, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 14, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
| Apr 14, 2025 | PETG | O | PETITION TO REVIVE-GRANTED |
| Apr 14, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
| Apr 14, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 12, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Feb 12, 2025 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Aug 18, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
| Jul 30, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jul 29, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Jul 2, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Jul 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 20, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Jun 20, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 13, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Biological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in industry and science; biological tissue, namely, human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; biological tissue, namely, human and animal cells from placentas for use in manufacturing biological cosmetic preparations for prevention of hair loss; isolated plant cells, their extracts, and components being botanical extracts, other than essential oils, for use in industry and science; biological tissue, namely, isolated and cultivated adherent cells from placenta tissue for use industry and science; biological tissue, namely, isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; biological tissue, namely, isolated and cultivated mammal cells, their extracts and components for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated fish cells and sea food being marine animal cells for use in industrial manufacture of foodstuffs; biological tissue, namely, isolated and cultivated plant cells and their extracts, other than essential oils, for use in industrial manufacture of foodstuffs
Class 005
Cells, their extracts and components and biological preparations intended for medical and clinical use for the treatment of cardiovascular diseases, Critical Limb Ischemia (CLI), muscle regeneration, Acute Radiation Syndrome (ARS), Delayed Effects of Acute Radiation Exposure (DEARE), hematological deficiencies, and pathogenic infectious; bioengineered cells and bioengineered tissue for medical and clinical use for the treatment of cancer; bioengineered cells for use in immunotherapies for treatment of cancer (solid tumors), pathogenic infectious diseases; bioengineered human T cells for medical and clinical use; human cells from placentas for medical and clinical use; dietary supplements based on human cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human cells from placentas for use in prevention of hair loss; isolated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use; isolated and cultivated adherent cells from placenta tissue for medical and clinical use; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for medical and clinical use; ; isolated and cultivated plant cells, their extracts and components being plant extracts, other than essential oils, for medical and clinical use and preparations containing the same for the treatment of inflammatory skin conditions, skin regeneration following burns and/or environmental damage, wound healing, anti-inflammatory processes (e.g., arthritis), maintaining and supporting gut health, boost immunity, and improve general energy levels.
Class 042
Scientific and technological services, namely, scientific research relating to isolation and culturing of animal cells and plant cells and to animal and plant tissues isolation and culturing, to biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, to bioengineered cells and tissues, to bioengineered cells for use in immunotherapy for cancer and other infectious diseases, to bioengineered human T cells, to isolated and cultivated human and animal placentas cells, to isolated plant cells and their extracts, to isolated and cultivated adherent cells from placenta tissue, to isolated and cultivated adherent stromal cells derived from placentas of multiple donors, to isolated and cultivated mammal cells, their extracts and preparations containing them, to isolated and cultivated fish cells and sea food cells and preparations containing the same, to isolated and cultivated plant cells and their extracts and preparations containing the same, to research, development and testing services in the fields of mass production of animal and plant cells, and to research, development and testing services in the fields of large scale production of various cells in bioreactors
Additional Information
Design Mark
The mark consists of the stylized word "PLURI", with the "P" and the "I" each having a shaded circle above them with a curved line extending between the circles.
Classification
International Classes
001
005
042